Skip to content
10-Q

Quarterly Report

NEOGENOMICS INC NEO

0001077183-26-000023

← back to feed
Filed
Apr 28, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 24, 2026 130.21M sh
Shares Diluted Q1 2026 · Mar 31, 2026 129.17M sh
Shares Diluted Q1 2026 · Mar 31, 2025 127.38M sh
Capex Q1 2026 · Mar 31, 2026 $5M
Capex Q1 2026 · Mar 31, 2025 $4.5M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$8.14M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$25.33M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $146.14M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $159.62M
Stockholders Equity Q1 2026 · Mar 31, 2026 $828.76M
Stockholders Equity Q1 2026 · Dec 31, 2025 $836.56M
Stockholders Equity Q1 2026 · Mar 31, 2025 $888.27M
Stockholders Equity Q1 2026 · Dec 31, 2024 $902.34M
Current Liabilities Q1 2026 · Mar 31, 2026 $84.59M
Current Liabilities Q1 2026 · Dec 31, 2025 $88.3M
Total Liabilities Q1 2026 · Mar 31, 2026 $517.77M
Total Liabilities Q1 2026 · Dec 31, 2025 $523.27M
Current Assets Q1 2026 · Mar 31, 2026 $373.68M
Current Assets Q1 2026 · Dec 31, 2025 $376.29M
Total Assets Q1 2026 · Mar 31, 2026 $1.35B
Total Assets Q1 2026 · Dec 31, 2025 $1.36B
Sga Expense Q1 2026 · Mar 31, 2026 $65.74M
Sga Expense Q1 2026 · Mar 31, 2025 $68.21M
Rd Expense Q1 2026 · Mar 31, 2026 $9.53M
Rd Expense Q1 2026 · Mar 31, 2025 $10.18M
Net Income Q1 2026 · Mar 31, 2026 −$17.11M
Net Income Q1 2026 · Mar 31, 2025 −$25.92M
Operating Income Q1 2026 · Mar 31, 2026 −$18.24M
Operating Income Q1 2026 · Mar 31, 2025 −$27.83M
Gross Profit Q1 2026 · Mar 31, 2026 $80.86M
Gross Profit Q1 2026 · Mar 31, 2025 $73.25M